US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist
  • 0.906
  • +0.012+1.33%
Close Nov 22 16:00 ET
  • 0.890
  • -0.016-1.71%
Post 20:01 ET
39.52MMarket Cap-591P/E (TTM)

About Tempest Therapeutics Company

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.

Company Profile

SymbolTPST
Company NameTempest Therapeutics
Listing DateApr 30, 2013
Founded2011
CEOMr. Stephen R. Brady
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 400
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-415-798-8589
Websitehttp://www.tempesttx.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen R. Brady
  • Director, Chief Executive Officer and President
  • 1.51M
  • Dr. Samuel Whiting, M.D.,PhD
  • Executive Vice President and Chief Medical Officer
  • 833.40K
  • Justin Trojanowski
  • Corporate Controller, Treasurer and Principal Accounting Officer
  • --
  • Nicholas Maestas
  • Principal Financial Officer, Secretary and Vice President, Strategy and Finance
  • --
  • Michael G. Raab
  • Chairman of the Board
  • 96.52K
  • Christine A. Pellizzari
  • Independent Director
  • 61.02K
  • Dr. Geoffrey M. Nichol, Ch.B.,M.B.,M.B.A.
  • Independent Director
  • 61.52K
  • Dr. Ronit Simantov, M.D.
  • Independent Director
  • 51.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data